The Society for Translational Medicine and The Chinese Society for Thoracic and Cardiovascular Surgery conducted a systematic review of the literature in an attempt to improve our understanding in the postoperative management of chest tubes of patients undergoing pulmonary lobectomy. Recommendations were produced and classified based on an internationally accepted GRADE system. The following recommendations were extracted in the present review: (I) chest tubes can be removed safely with daily pleural fluid of up to 450 mL (non-chylous and non-sanguinous), which may reduce chest tube duration and hospital length of stay (2B); (II) in rare instances, e.g., persistent abundant fluid production, the use of PrR(P/B) <0.5 when evaluating fluid output to determine chest tube removal might be beneficial (2B); (III) it is recommended that one chest tube is adequate following pulmonary lobectomy, except for hemorrhage and space problems (2A); (IV) chest tube clearance by milking and stripping is not recommended after lung resection (2B); (V) chest tube suction is not necessary for patients undergoing lobectomy after first postoperative day (2A); (VI) regulated chest tube suction [-11 (-1.08 kPa) to -20 (1.96 kPa) cmH(2)O depending upon the type of lobectomy] is not superior to regulated seal [-2 (0.196 kPa) cmH(2)O] when electronic drainage systems are used after lobectomy by thoracotomy (2B); (VII) chest tube removal recommended at the end of expiration and may be slightly superior to removal at the end of inspiration (2A); (VIII) electronic drainage systems are recommended in the management of chest tube in patients undergoing lobectomy (2B).
The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy.
阅读:7
作者:Gao Shugeng, Zhang Zhongheng, Aragón Javier, Brunelli Alessandro, Cassivi Stephen, Chai Ying, Chen Chang, Chen Chun, Chen Gang, Chen Haiquan, Chen Jin-Shing, Cooke David Tom, Downs John B, Falcoz Pierre-Emmanuel, Fang Wentao, Filosso Pier Luigi, Fu Xiangning, Force Seth D, Garutti MartÃnez I, Gonzalez-Rivas Diego, Gossot Dominique, Hansen Henrik Jessen, He Jianxing, He Jie, Holbek Bo Laksáfoss, Hu Jian, Huang Yunchao, Ibrahim Mohsen, Imperatori Andrea, Ismail Mahmoud, Jiang Gening, Jiang Hongjing, Jiang Zhongmin, Kim Hyun Koo, Li Danqing, Li Gaofeng, Li Hui, Li Qiang, Li Xiaofei, Li Yin, Li Zhijun, Lim Eric, Liu Chia-Chuan, Liu Deruo, Liu Lunxu, Liu Yongyi, Lobdell Kevin W, Ma Haitao, Mao Weimin, Mao Yousheng, Mou Juwei, Ng Calvin Sze Hang, Novoa Nuria M, Petersen René H, Oizumi Hiroyuki, Papagiannopoulos Kostas, Pompili Cecilia, Qiao Guibin, Refai Majed, Rocco Gaetano, Ruffini Erico, Salati Michele, Seguin-Givelet Agathe, Sihoe Alan Dart Loon, Tan Lijie, Tan Qunyou, Tong Tang, Tsakiridis Kosmas, Venuta Federico, Veronesi Giulia, Villamizar Nestor, Wang Haidong, Wang Qun, Wang Ruwen, Wang Shumin, Wright Gavin M, Xie Deyao, Xue Qi, Xue Tao, Xu Lin, Xu Shidong, Xu Songtao, Yan Tiansheng, Yu Fenglei, Yu Zhentao, Zhang Chunfang, Zhang Lanjun, Zhang Tao, Zhang Xun, Zhao Xiaojing, Zhao Xuewei, Zhi Xiuyi, Zhou Qinghua
| 期刊: | Journal of Thoracic Disease | 影响因子: | 1.900 |
| 时间: | 2017 | 起止号: | 2017 Sep;9(9):3255-3264 |
| doi: | 10.21037/jtd.2017.08.165 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
